Research programme: DNA minor groove binders - MGB Biopharma

Drug Profile

Research programme: DNA minor groove binders - MGB Biopharma

Alternative Names: AfMGB; ApMGB

Latest Information Update: 01 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator MGB Biopharma
  • Class Antifungals; Antiparasitics; Antivirals; DNA-binding proteins; Small molecules
  • Mechanism of Action Genetic transcription inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Mycoses; Parasitic infections

Highest Development Phases

  • Research Mycoses; Parasitic infections; Viral infections

Most Recent Events

  • 01 Jun 2018 Early research is ongoing in Parasitic infections nad Mycoses in United Kingdom (unspecified route) (MGB Biopharma pipeline, June 2018)
  • 01 Jun 2018 Early research in Viral infections in United Kingdom (unspecified route)
  • 16 Jul 2016 No recent reports of development identified for research development in Mycoses in United Kingdom
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top